RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Genor Biopharma Holdings Stock

Genor Biopharma Holdings Net Income 2025

Genor Biopharma Holdings Net Income

-51.28 M CNY

Ticker

6998.HK

ISIN

KYG3871A1004

WKN

A3C3E0

In 2025, Genor Biopharma Holdings's profit amounted to -51.28 M CNY, a -92.4% increase from the -674.36 M CNY profit recorded in the previous year.

The Genor Biopharma Holdings Net Income history

YEARNET INCOME (undefined CNY)
2024-
2023-
2022-
2021-
2020-
2019-
2018-

Genor Biopharma Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Genor Biopharma Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Genor Biopharma Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Genor Biopharma Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Genor Biopharma Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Genor Biopharma Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Genor Biopharma Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Genor Biopharma Holdings’s growth potential.

Genor Biopharma Holdings Revenue, EBIT and net profit per share

DateGenor Biopharma Holdings RevenueGenor Biopharma Holdings EBITGenor Biopharma Holdings Net Income
2024206.23 M undefined-40.97 M undefined-51.28 M undefined
20230 undefined-702.27 M undefined-674.36 M undefined
202215.93 M undefined-782.72 M undefined-730.21 M undefined
20210 undefined-875.41 M undefined-865.22 M undefined
202010.33 M undefined-2.9 B undefined-3.03 B undefined
201913.04 M undefined-520.5 M undefined-522.08 M undefined
20186.88 M undefined-281.64 M undefined-288.08 M undefined

Genor Biopharma Holdings stock margins

The Genor Biopharma Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genor Biopharma Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genor Biopharma Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Genor Biopharma Holdings's sales revenue. A higher gross margin percentage indicates that the Genor Biopharma Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Genor Biopharma Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Genor Biopharma Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Genor Biopharma Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Genor Biopharma Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Genor Biopharma Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Genor Biopharma Holdings Margin History

Genor Biopharma Holdings Gross marginGenor Biopharma Holdings Profit marginGenor Biopharma Holdings EBIT marginGenor Biopharma Holdings Profit margin
202499.35 %-19.86 %-24.87 %
202399.35 %0 %0 %
202293.83 %-4,912.87 %-4,583.32 %
202199.35 %0 %0 %
202074.87 %-28,094.77 %-29,301.15 %
201926.67 %-3,991.86 %-4,004 %
201820.78 %-4,092.42 %-4,185.95 %

Genor Biopharma Holdings Aktienanalyse

What does Genor Biopharma Holdings do?

Genor Biopharma Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Genor Biopharma Holdings's Profit Margins

The profit margins of Genor Biopharma Holdings represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Genor Biopharma Holdings's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Genor Biopharma Holdings's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Genor Biopharma Holdings's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Genor Biopharma Holdings’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Genor Biopharma Holdings stock

How much profit has Genor Biopharma Holdings made this year?

Genor Biopharma Holdings has made -51.28 M CNY this year.

How has the profit developed compared to last year?

The profit has increased by -92.4% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Genor Biopharma Holdings publish its earnings?

Genor Biopharma Holdings publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Genor Biopharma Holdings?

The profits of Genor Biopharma Holdings are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Genor Biopharma Holdings?

You can learn more about the earnings of Genor Biopharma Holdings by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Genor Biopharma Holdings pay?

Over the past 12 months, Genor Biopharma Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genor Biopharma Holdings is expected to pay a dividend of 0 CNY.

What is the dividend yield of Genor Biopharma Holdings?

The current dividend yield of Genor Biopharma Holdings is .

When does Genor Biopharma Holdings pay dividends?

Genor Biopharma Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genor Biopharma Holdings?

Genor Biopharma Holdings paid dividends every year for the past 0 years.

What is the dividend of Genor Biopharma Holdings?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genor Biopharma Holdings located?

Genor Biopharma Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genor Biopharma Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genor Biopharma Holdings from 8/4/2025 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 8/4/2025.

When did Genor Biopharma Holdings pay the last dividend?

The last dividend was paid out on 8/4/2025.

What was the dividend of Genor Biopharma Holdings in the year 2024?

In the year 2024, Genor Biopharma Holdings distributed 0 CNY as dividends.

In which currency does Genor Biopharma Holdings pay out the dividend?

The dividends of Genor Biopharma Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Genor Biopharma Holdings

Our stock analysis for Genor Biopharma Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genor Biopharma Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.